<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000306509"><TermName>molecular risk assessment</TermName><TermPronunciation>(muh-LEH-kyoo-ler risk uh-SES-ment)</TermPronunciation><TermDefinition><DefinitionText>A procedure in which biomarkers (for example, biological molecules or changes in tumor cell DNA) are used to estimate a person’s risk for developing cancer. Specific biomarkers may be linked to particular types of cancer.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000731606" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;molecular risk assessment&quot;" language="en" id="_3"/><MediaLink ref="CDR0000731607" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;evaluación molecular del riesgo&quot;" language="es" id="_4"/><SpanishTermName>evaluación molecular del riesgo</SpanishTermName><SpanishTermDefinition><DefinitionText>Procedimiento mediante el cual se utilizan biomarcadores (por ejemplo, moléculas biológicas o cambios en el ADN de la célula tumoral) para calcular el riesgo de contraer cáncer que tiene una persona. Se pueden vincular biomarcadores específicos con tipos particulares de cáncer.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2003-05-23</DateFirstPublished></GlossaryTerm>
